{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:48:07Z","timestamp":1782841687725,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073376"],"award-info":[{"award-number":["82073376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017352","name":"Beijing Shijitan Hospital Capital Medical University Department of Peritoneal surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejso.2022.08.023","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T01:31:30Z","timestamp":1661650290000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical epidemiology of peritoneal metastases in China: The construction of professional peritoneal metastases treatment centers based on the prevalence rate"],"prefix":"10.1016","volume":"49","author":[{"given":"Rui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-dong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6843-5129","authenticated-orcid":false,"given":"Ru","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6018-6538","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.ejso.2022.08.023_bib1","first-page":"1685","article-title":"My opinion on peritoneal metastasis research","volume":"39","author":"Li","year":"2012","journal-title":"Chin J Clin Oncol"},{"issue":"30","key":"10.1016\/j.ejso.2022.08.023_bib2","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.3748\/wjg.v22.i30.6906","article-title":"Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies","volume":"22","author":"Li","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.023_bib3","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"Ca - Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.023_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10120-014-0385-8","article-title":"Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution","volume":"18","author":"Koo","year":"2015","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2022.08.023_bib5","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in metastases of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.08.023_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2014.07.004","article-title":"The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer","volume":"134","author":"Rosen","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2022.08.023_bib7","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with Pseudomyxoma Peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.08.023_bib8","first-page":"1","article-title":"Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study","author":"van Kooten","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.ejso.2022.08.023_bib9","series-title":"China statistical Yearbook 2021","author":"Ning","year":"2021"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.023_bib10","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10120-019-00969-1","article-title":"The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis","volume":"22","author":"Rau","year":"2019","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2022.08.023_bib11","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ejso.2019.07.008","article-title":"Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM)","volume":"45","author":"Larentzakis","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2022.08.023_bib12","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","article-title":"Malignant peritoneal mesothelioma: national practice patterns, outcomes, and predictors of survival","volume":"25","author":"Verma","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1 Pt B","key":"10.1016\/j.ejso.2022.08.023_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.amjsurg.2022.01.024","article-title":"Patterns of gastric cancer metastasis in the United States","volume":"224","author":"Sirody","year":"2022","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.023_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejso.2006.03.003","article-title":"Quantitative prognostic indicators of peritoneal dissemination of gastric cancer","volume":"32","author":"Yonemura","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2022.08.023_bib15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ejso.2013.10.001","article-title":"Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer","volume":"40","author":"van Gestel","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.08.023_bib16","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2022.08.023_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.ejso.2022.08.023_bib18","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bjc.2013.82","article-title":"Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades","volume":"108","author":"Kerscher","year":"2013","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2022.08.023_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/DCR.0000000000000412","article-title":"Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study","volume":"58","author":"Quere","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.023_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/bjs5.50247","article-title":"Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study","volume":"4","author":"Ravn","year":"2020","journal-title":"BJS Open"},{"issue":"10177","key":"10.1016\/j.ejso.2022.08.023_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2022.08.023_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2022.0143","article-title":"Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial","author":"Lim","year":"2022","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.ejso.2022.08.023_bib23","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.023_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1245\/s10434-020-08655-8","article-title":"Estimating the prevalence of pseudomyxoma peritonei in Europe using a novel statistical method","volume":"28","author":"Patrick-Brown","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.023_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bjs5.97","article-title":"Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"3","author":"Mercier","year":"2018","journal-title":"BJS Open"},{"issue":"3","key":"10.1016\/j.ejso.2022.08.023_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/DCR.0b013e318202f026","article-title":"Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin","volume":"54","author":"Youssef","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.ejso.2022.08.023_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.21147\/j.issn.1000-9604.2017.04.09","article-title":"Epidemiology and trend analysis on malignant mesothelioma in China","volume":"29","author":"Zhao","year":"2017","journal-title":"Chin J Cancer Res"},{"issue":"3","key":"10.1016\/j.ejso.2022.08.023_bib28","first-page":"230","article-title":"Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy","volume":"24","author":"Yu","year":"2021","journal-title":"Chin J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.ejso.2022.08.023_bib29","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1186\/s12885-020-07601-x","article-title":"Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Cancer"},{"issue":"27","key":"10.1016\/j.ejso.2022.08.023_bib30","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: optimal management review","volume":"25","author":"Sanchez-Hidalgo","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.023_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejso.2015.11.006","article-title":"Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: long-term outcomes and perspectives from a high-volume center","volume":"42","author":"Munoz-Casares","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"36","key":"10.1016\/j.ejso.2022.08.023_bib32","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.023_bib33","first-page":"89","article-title":"Expert consensus on clinical application of hyperthermic intraperitoneal chemotherapy in China (2019)","volume":"100","year":"2020","journal-title":"Natl Med J China (Peking)"},{"issue":"2","key":"10.1016\/j.ejso.2022.08.023_bib34","first-page":"194","article-title":"Clinical Application Expert Collaborative Group of Chinese Gynecological Hyperthermic Intraperitoneal Chemotherapy. Expert consensus on clinical application of hyperthermic intraperitoneal chemotherapy for gynecological malignant tumors (2019)","volume":"35","year":"2019","journal-title":"Chin J Pract Surg"},{"issue":"20","key":"10.1016\/j.ejso.2022.08.023_bib35","first-page":"1527","article-title":"Expert consensus on cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in the treatment of pseudomyxoma peritonei","volume":"99","author":"Li","year":"2019","journal-title":"Natl Med J China (Peking)"},{"issue":"4","key":"10.1016\/j.ejso.2022.08.023_bib36","first-page":"329","article-title":"Chinese expert consensus for prophylactic and therapeutic intraperitoneal medication for peritoneal metastases from colorectal cancer (2019)","volume":"8","year":"2019","journal-title":"Chin J Colorec Dis (Electronic Edition)"},{"issue":"36","key":"10.1016\/j.ejso.2022.08.023_bib37","first-page":"2839","volume":"101","year":"2021","journal-title":"Natl Med J China (Peking)"},{"key":"10.1016\/j.ejso.2022.08.023_bib38","series-title":"China Health statistical Yearbook","author":"Wu","year":"2021"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:46:18Z","timestamp":1760060778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322006308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0748798322006308"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.08.023","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical epidemiology of peritoneal metastases in China: The construction of professional peritoneal metastases treatment centers based on the prevalence rate","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}